

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endothelium development (GO:0003158) | 6.22647054 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.15342096 |
| 3 | positive regulation of vasculogenesis (GO:2001214) | 4.16547945 |
| 4 | lymphangiogenesis (GO:0001946) | 4.15382023 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 4.07139495 |
| 6 | blood vessel maturation (GO:0001955) | 4.00046387 |
| 7 | cellular response to ATP (GO:0071318) | 3.97779771 |
| 8 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.97067394 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 3.87859460 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 3.87859460 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 3.87859460 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.87859460 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.87859460 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.87859460 |
| 15 | ribosomal small subunit assembly (GO:0000028) | 3.86638743 |
| 16 | regulation of vasculogenesis (GO:2001212) | 3.85125873 |
| 17 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.79668711 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.67977492 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 3.64002979 |
| 20 | morphogenesis of an endothelium (GO:0003159) | 3.61343869 |
| 21 | endothelial tube morphogenesis (GO:0061154) | 3.61343869 |
| 22 | negative regulation of platelet activation (GO:0010544) | 3.58423491 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.54616727 |
| 24 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.52827643 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.50030620 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.50030620 |
| 27 | definitive hemopoiesis (GO:0060216) | 3.43147376 |
| 28 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.39603619 |
| 29 | sulfation (GO:0051923) | 3.37874477 |
| 30 | regulation of glomerulus development (GO:0090192) | 3.37585636 |
| 31 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.34128607 |
| 32 | positive regulation of B cell differentiation (GO:0045579) | 3.32985057 |
| 33 | myeloid dendritic cell activation (GO:0001773) | 3.32520763 |
| 34 | response to muramyl dipeptide (GO:0032495) | 3.31641718 |
| 35 | response to interferon-beta (GO:0035456) | 3.30857167 |
| 36 | response to peptidoglycan (GO:0032494) | 3.30695216 |
| 37 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.28693140 |
| 38 | positive regulation of interferon-alpha production (GO:0032727) | 3.27168757 |
| 39 | positive regulation of antigen processing and presentation (GO:0002579) | 3.26348701 |
| 40 | neutrophil activation (GO:0042119) | 3.26108325 |
| 41 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.24962288 |
| 42 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.21791618 |
| 43 | regulation of cholesterol storage (GO:0010885) | 3.19759399 |
| 44 | regulation of sequestering of triglyceride (GO:0010889) | 3.17027118 |
| 45 | endothelial cell differentiation (GO:0045446) | 3.14580051 |
| 46 | keratan sulfate catabolic process (GO:0042340) | 3.09279338 |
| 47 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.09268301 |
| 48 | sprouting angiogenesis (GO:0002040) | 3.08891317 |
| 49 | myeloid dendritic cell differentiation (GO:0043011) | 3.08627131 |
| 50 | regulation of interferon-alpha production (GO:0032647) | 3.07179231 |
| 51 | defense response to protozoan (GO:0042832) | 3.06997760 |
| 52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.04865679 |
| 53 | cellular response to interferon-beta (GO:0035458) | 3.02954206 |
| 54 | viral transcription (GO:0019083) | 3.01524244 |
| 55 | tooth mineralization (GO:0034505) | 3.01373649 |
| 56 | B cell mediated immunity (GO:0019724) | 3.00688303 |
| 57 | NIK/NF-kappaB signaling (GO:0038061) | 2.99545313 |
| 58 | regulation of antigen processing and presentation (GO:0002577) | 2.98612869 |
| 59 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.97218426 |
| 60 | axon extension involved in axon guidance (GO:0048846) | 2.96932423 |
| 61 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.96932423 |
| 62 | granulocyte activation (GO:0036230) | 2.95225871 |
| 63 | regulation of B cell differentiation (GO:0045577) | 2.93045358 |
| 64 | negative regulation of response to food (GO:0032096) | 2.93043802 |
| 65 | negative regulation of appetite (GO:0032099) | 2.93043802 |
| 66 | respiratory burst (GO:0045730) | 2.92663986 |
| 67 | superoxide anion generation (GO:0042554) | 2.91793273 |
| 68 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.90778219 |
| 69 | vitamin biosynthetic process (GO:0009110) | 2.89712109 |
| 70 | negative regulation of fibrinolysis (GO:0051918) | 2.88448514 |
| 71 | wound healing, spreading of epidermal cells (GO:0035313) | 2.88328853 |
| 72 | response to nitrosative stress (GO:0051409) | 2.87968166 |
| 73 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.86243610 |
| 74 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.86243610 |
| 75 | mature B cell differentiation (GO:0002335) | 2.85064431 |
| 76 | translational termination (GO:0006415) | 2.83497635 |
| 77 | macrophage activation involved in immune response (GO:0002281) | 2.82759998 |
| 78 | negative regulation of lipid storage (GO:0010888) | 2.79416124 |
| 79 | regulation of endothelial cell differentiation (GO:0045601) | 2.78999200 |
| 80 | dendritic cell chemotaxis (GO:0002407) | 2.78656282 |
| 81 | response to protozoan (GO:0001562) | 2.78567082 |
| 82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.77126961 |
| 83 | ribosomal small subunit biogenesis (GO:0042274) | 2.76717095 |
| 84 | negative chemotaxis (GO:0050919) | 2.75637836 |
| 85 | negative regulation of endothelial cell migration (GO:0010596) | 2.75470637 |
| 86 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.75469294 |
| 87 | xenobiotic catabolic process (GO:0042178) | 2.74970969 |
| 88 | mast cell activation (GO:0045576) | 2.74757073 |
| 89 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.74644632 |
| 90 | myeloid cell activation involved in immune response (GO:0002275) | 2.73838074 |
| 91 | germinal center formation (GO:0002467) | 2.73727420 |
| 92 | pinocytosis (GO:0006907) | 2.73611355 |
| 93 | Notch signaling involved in heart development (GO:0061314) | 2.72514321 |
| 94 | regulation of mast cell activation (GO:0033003) | 2.72163558 |
| 95 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.71913956 |
| 96 | cellular extravasation (GO:0045123) | 2.71491007 |
| 97 | cellular response to type I interferon (GO:0071357) | 2.71023869 |
| 98 | type I interferon signaling pathway (GO:0060337) | 2.71023869 |
| 99 | organ induction (GO:0001759) | 2.70995315 |
| 100 | response to type I interferon (GO:0034340) | 2.70552141 |
| 101 | cellular response to exogenous dsRNA (GO:0071360) | 2.70219217 |
| 102 | organ formation (GO:0048645) | 2.70035933 |
| 103 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.69410262 |
| 104 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.69233687 |
| 105 | regulation of mast cell degranulation (GO:0043304) | 2.68961791 |
| 106 | B cell receptor signaling pathway (GO:0050853) | 2.66929673 |
| 107 | mature B cell differentiation involved in immune response (GO:0002313) | 2.66662637 |
| 108 | T-helper 1 type immune response (GO:0042088) | 2.66358425 |
| 109 | negative regulation of axon guidance (GO:1902668) | 2.65886645 |
| 110 | dendritic cell differentiation (GO:0097028) | 2.65785452 |
| 111 | regulation of necroptotic process (GO:0060544) | 2.64728282 |
| 112 | response to host immune response (GO:0052572) | 2.64569838 |
| 113 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.64569838 |
| 114 | negative regulation of protein autophosphorylation (GO:0031953) | 2.64470714 |
| 115 | endothelial cell proliferation (GO:0001935) | 2.63078791 |
| 116 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.62321026 |
| 117 | negative regulation of mast cell activation (GO:0033004) | 2.60638841 |
| 118 | cellular response to zinc ion (GO:0071294) | 2.60629236 |
| 119 | positive regulation of urine volume (GO:0035810) | 2.60320639 |
| 120 | negative regulation of B cell proliferation (GO:0030889) | 2.59875103 |
| 121 | negative regulation of phagocytosis (GO:0050765) | 2.59662931 |
| 122 | response to interferon-alpha (GO:0035455) | 2.59628925 |
| 123 | megakaryocyte development (GO:0035855) | 2.58917745 |
| 124 | platelet dense granule organization (GO:0060155) | 2.58647420 |
| 125 | myeloid leukocyte activation (GO:0002274) | 2.58555705 |
| 126 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.57351097 |
| 127 | dendritic cell migration (GO:0036336) | 2.57194383 |
| 128 | microglial cell activation (GO:0001774) | 2.56786295 |
| 129 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.55645786 |
| 130 | positive regulation of interferon-beta production (GO:0032728) | 2.53709779 |
| 131 | regulation of mononuclear cell migration (GO:0071675) | 2.53697159 |
| 132 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.53592924 |
| 133 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.53487614 |
| 134 | positive regulation of interleukin-12 production (GO:0032735) | 2.51463084 |
| 135 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.51367501 |
| 136 | cellular response to BMP stimulus (GO:0071773) | 2.51199454 |
| 137 | response to BMP (GO:0071772) | 2.51199454 |
| 138 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.51125213 |
| 139 | brown fat cell differentiation (GO:0050873) | 2.50896767 |
| 140 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.50368294 |
| 141 | negative regulation of complement activation (GO:0045916) | 2.49753019 |
| 142 | negative regulation of granulocyte differentiation (GO:0030853) | 2.48990470 |
| 143 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.48071375 |
| 144 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.48036182 |
| 145 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.47966122 |
| 146 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.47542316 |
| 147 | signal peptide processing (GO:0006465) | 2.46261041 |
| 148 | cell proliferation in forebrain (GO:0021846) | 2.46015228 |
| 149 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.45481096 |
| 150 | cotranslational protein targeting to membrane (GO:0006613) | 2.44912038 |
| 151 | positive regulation of defense response to virus by host (GO:0002230) | 2.44663800 |
| 152 | histamine secretion (GO:0001821) | 2.44331100 |
| 153 | regulation of RIG-I signaling pathway (GO:0039535) | 2.43922242 |
| 154 | protein targeting to ER (GO:0045047) | 2.43104312 |
| 155 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.42580540 |
| 156 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.41962694 |
| 157 | alpha-linolenic acid metabolic process (GO:0036109) | 2.41703488 |
| 158 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.41487453 |
| 159 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.40813689 |
| 160 | basement membrane organization (GO:0071711) | 2.40705741 |
| 161 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.40339013 |
| 162 | * angiogenesis involved in wound healing (GO:0060055) | 2.39662317 |
| 163 | positive regulation of fatty acid oxidation (GO:0046321) | 2.39655000 |
| 164 | T cell homeostasis (GO:0043029) | 2.37534028 |
| 165 | positive regulation of macrophage differentiation (GO:0045651) | 2.37493728 |
| 166 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.37237960 |
| 167 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.37197641 |
| 168 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.37161849 |
| 169 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.36509763 |
| 170 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.35874620 |
| 171 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.34987826 |
| 172 | positive regulation of glomerulus development (GO:0090193) | 2.34985266 |
| 173 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.33835895 |
| 174 | negative regulation of coagulation (GO:0050819) | 2.33021075 |
| 175 | estrogen metabolic process (GO:0008210) | 2.32040345 |
| 176 | lymph vessel development (GO:0001945) | 2.31894604 |
| 177 | negative regulation of protein activation cascade (GO:2000258) | 2.31652240 |
| 178 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.30892447 |
| 179 | L-ascorbic acid metabolic process (GO:0019852) | 2.30875645 |
| 180 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.29259018 |
| 181 | regulation of urine volume (GO:0035809) | 2.28913501 |
| 182 | endoderm formation (GO:0001706) | 2.28875067 |
| 183 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.28280926 |
| 184 | regulation of smooth muscle cell migration (GO:0014910) | 2.26523711 |
| 185 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.26203174 |
| 186 | presynaptic membrane assembly (GO:0097105) | 2.25893199 |
| 187 | GPI anchor metabolic process (GO:0006505) | 2.25194392 |
| 188 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.24597538 |
| 189 | artery development (GO:0060840) | 2.24182265 |
| 190 | cobalamin metabolic process (GO:0009235) | 2.24086603 |
| 191 | lysine catabolic process (GO:0006554) | 2.22885766 |
| 192 | lysine metabolic process (GO:0006553) | 2.22885766 |
| 193 | opsonization (GO:0008228) | 2.22697204 |
| 194 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.22153383 |
| 195 | protein kinase C signaling (GO:0070528) | 2.19582236 |
| 196 | bile acid biosynthetic process (GO:0006699) | 2.19337313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.39128226 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.09691270 |
| 3 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.95420880 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.59691971 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.09980181 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.67480364 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.43838343 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.38348628 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.32481775 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.18959805 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.99233741 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.71889780 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.71564034 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.68903122 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.59519873 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.56200525 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53242682 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.51773349 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.50031256 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.46726495 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.40495912 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.29887730 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26097601 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.19311108 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18842463 |
| 26 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.10095756 |
| 27 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.09608355 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.09369973 |
| 29 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.08404087 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.07615738 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.06438601 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.01022641 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.00525175 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.93018022 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.90473089 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.89859975 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85800494 |
| 38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85520244 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84326453 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.81326219 |
| 41 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.79268300 |
| 42 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76303130 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.75458439 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73067045 |
| 45 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.72748818 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.72406578 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72138015 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69339527 |
| 49 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.68177480 |
| 50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66490023 |
| 51 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66407204 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.66046712 |
| 53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65558966 |
| 54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.63420326 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.62402018 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62388999 |
| 57 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.61427983 |
| 58 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.60724754 |
| 59 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.59762473 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.59377995 |
| 61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55720859 |
| 62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.55478436 |
| 63 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.53931095 |
| 64 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.53270629 |
| 65 | CJUN_26792858_Chip-Seq_BT549_Human | 1.51368361 |
| 66 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49496052 |
| 67 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.44448152 |
| 68 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.43760589 |
| 69 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.43054683 |
| 70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39369227 |
| 71 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.39265004 |
| 72 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.38161906 |
| 73 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.37474594 |
| 74 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.37170559 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36942021 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35863237 |
| 77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34876977 |
| 78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34876977 |
| 79 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.34496147 |
| 80 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33699528 |
| 81 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.33519280 |
| 82 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.33286030 |
| 83 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.33257274 |
| 84 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.33147657 |
| 85 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.33024313 |
| 86 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.32696335 |
| 87 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31945765 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31804205 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.31001238 |
| 90 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30173756 |
| 91 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28704613 |
| 92 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28645425 |
| 93 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26297937 |
| 94 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.25692627 |
| 95 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.24355658 |
| 96 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24277648 |
| 97 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.24277221 |
| 98 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.24234625 |
| 99 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24067803 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24067203 |
| 101 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.23864363 |
| 102 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23583116 |
| 103 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.23355267 |
| 104 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20136886 |
| 105 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.19457312 |
| 106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19233432 |
| 107 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.19066182 |
| 108 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19026417 |
| 109 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19026417 |
| 110 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17381639 |
| 111 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.17181359 |
| 112 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.16987818 |
| 113 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16987386 |
| 114 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.16220986 |
| 115 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.15653930 |
| 116 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.14688325 |
| 117 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13741004 |
| 118 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.13439935 |
| 119 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13138429 |
| 120 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.13114190 |
| 121 | TP53_16413492_ChIP-PET_HCT116_Human | 1.12555688 |
| 122 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12269661 |
| 123 | EWS_26573619_Chip-Seq_HEK293_Human | 1.11868399 |
| 124 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11799584 |
| 125 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.11197056 |
| 126 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.11018014 |
| 127 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.09434741 |
| 128 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.09434741 |
| 129 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.09434741 |
| 130 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.08788788 |
| 131 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08587894 |
| 132 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08014854 |
| 133 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07147549 |
| 134 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06672764 |
| 135 | VDR_22108803_ChIP-Seq_LS180_Human | 1.06438679 |
| 136 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.06354756 |
| 137 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05474399 |
| 138 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04946552 |
| 139 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.04091847 |
| 140 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02269277 |
| 141 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.00383933 |
| 142 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99961301 |
| 143 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.99058317 |
| 144 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98958480 |
| 145 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98343793 |
| 146 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97915982 |
| 147 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.97537564 |
| 148 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.96582948 |
| 149 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96249974 |
| 150 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95889461 |
| 151 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95869525 |
| 152 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95825704 |
| 153 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.94604119 |
| 154 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94407610 |
| 155 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93897432 |
| 156 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.92997175 |
| 157 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.92669925 |
| 158 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.91940185 |
| 159 | MAF_26560356_Chip-Seq_TH2_Human | 0.91576711 |
| 160 | AR_20517297_ChIP-Seq_VCAP_Human | 0.91430404 |
| 161 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.91294464 |
| 162 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.91112585 |
| 163 | MYC_22102868_ChIP-Seq_BL_Human | 0.91040709 |
| 164 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.90529373 |
| 165 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.90404337 |
| 166 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90402917 |
| 167 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.90285170 |
| 168 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89470194 |
| 169 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.89405801 |
| 170 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.89351334 |
| 171 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.88989144 |
| 172 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.88937591 |
| 173 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.88937591 |
| 174 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.88819564 |
| 175 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88416363 |
| 176 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.88277102 |
| 177 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.87863236 |
| 178 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87301495 |
| 179 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.86277577 |
| 180 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.85145434 |
| 181 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.84916119 |
| 182 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84338541 |
| 183 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.84309230 |
| 184 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83372436 |
| 185 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81167773 |
| 186 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.80886465 |
| 187 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80549406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.58760041 |
| 2 | MP0004272_abnormal_basement_membrane | 3.32646098 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 2.93246051 |
| 4 | MP0003724_increased_susceptibility_to | 2.89357253 |
| 5 | MP0003011_delayed_dark_adaptation | 2.81111530 |
| 6 | MP0009785_altered_susceptibility_to | 2.79578901 |
| 7 | MP0005671_abnormal_response_to | 2.76757406 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.63604669 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.61976987 |
| 10 | MP0003436_decreased_susceptibility_to | 2.58899729 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.57529366 |
| 12 | MP0002419_abnormal_innate_immunity | 2.55197242 |
| 13 | MP0000685_abnormal_immune_system | 2.54501584 |
| 14 | MP0001800_abnormal_humoral_immune | 2.53924391 |
| 15 | MP0005025_abnormal_response_to | 2.52138477 |
| 16 | MP0001790_abnormal_immune_system | 2.41126901 |
| 17 | MP0005387_immune_system_phenotype | 2.41126901 |
| 18 | MP0002723_abnormal_immune_serum | 2.31968141 |
| 19 | MP0003195_calcinosis | 2.30076029 |
| 20 | MP0001819_abnormal_immune_cell | 2.26832832 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.25897477 |
| 22 | MP0009053_abnormal_anal_canal | 2.03858644 |
| 23 | MP0005174_abnormal_tail_pigmentation | 2.00741363 |
| 24 | MP0003646_muscle_fatigue | 1.98796767 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.96953225 |
| 26 | MP0002398_abnormal_bone_marrow | 1.95619181 |
| 27 | MP0001853_heart_inflammation | 1.95453762 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 1.93605499 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.93605499 |
| 30 | MP0006054_spinal_hemorrhage | 1.93404508 |
| 31 | MP0006082_CNS_inflammation | 1.86026648 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.84560540 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.84346815 |
| 34 | MP0000716_abnormal_immune_system | 1.83163323 |
| 35 | MP0002295_abnormal_pulmonary_circulatio | 1.80006790 |
| 36 | MP0001879_abnormal_lymphatic_vessel | 1.79399613 |
| 37 | MP0003303_peritoneal_inflammation | 1.75356569 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.74811635 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.74395910 |
| 40 | MP0002405_respiratory_system_inflammati | 1.74354224 |
| 41 | MP0004147_increased_porphyrin_level | 1.69786766 |
| 42 | MP0009384_cardiac_valve_regurgitation | 1.68611364 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.67563939 |
| 44 | MP0005595_abnormal_vascular_smooth | 1.65506945 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.64968383 |
| 46 | MP0000490_abnormal_crypts_of | 1.63563991 |
| 47 | MP0002429_abnormal_blood_cell | 1.62125781 |
| 48 | MP0002653_abnormal_ependyma_morphology | 1.61677888 |
| 49 | MP0002006_tumorigenesis | 1.59439142 |
| 50 | MP0002722_abnormal_immune_system | 1.56813543 |
| 51 | MP0000049_abnormal_middle_ear | 1.53311808 |
| 52 | MP0003828_pulmonary_edema | 1.51721365 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.47574824 |
| 54 | MP0008057_abnormal_DNA_replication | 1.47389273 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.44776882 |
| 56 | MP0009278_abnormal_bone_marrow | 1.42302768 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.41277206 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.40443138 |
| 59 | MP0001485_abnormal_pinna_reflex | 1.40373224 |
| 60 | MP0000604_amyloidosis | 1.39706115 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.38781677 |
| 62 | MP0002132_abnormal_respiratory_system | 1.36859412 |
| 63 | MP0002282_abnormal_trachea_morphology | 1.33914316 |
| 64 | MP0010368_abnormal_lymphatic_system | 1.33713522 |
| 65 | MP0008438_abnormal_cutaneous_collagen | 1.32725827 |
| 66 | MP0009379_abnormal_foot_pigmentation | 1.30460998 |
| 67 | MP0001986_abnormal_taste_sensitivity | 1.30139264 |
| 68 | MP0003448_altered_tumor_morphology | 1.29310219 |
| 69 | MP0000343_altered_response_to | 1.28504551 |
| 70 | MP0001873_stomach_inflammation | 1.27642354 |
| 71 | MP0004510_myositis | 1.27472444 |
| 72 | MP0005310_abnormal_salivary_gland | 1.26965506 |
| 73 | MP0003633_abnormal_nervous_system | 1.26143680 |
| 74 | MP0009764_decreased_sensitivity_to | 1.26012638 |
| 75 | MP0002837_dystrophic_cardiac_calcinosis | 1.25336926 |
| 76 | MP0000516_abnormal_urinary_system | 1.22185322 |
| 77 | MP0005367_renal/urinary_system_phenotyp | 1.22185322 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 1.20244999 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 1.18020547 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 1.16554320 |
| 81 | MP0008469_abnormal_protein_level | 1.16146806 |
| 82 | MP0002095_abnormal_skin_pigmentation | 1.15657191 |
| 83 | MP0008775_abnormal_heart_ventricle | 1.15337292 |
| 84 | MP0005165_increased_susceptibility_to | 1.14698182 |
| 85 | MP0008007_abnormal_cellular_replicative | 1.13099507 |
| 86 | MP0003075_altered_response_to | 1.12384753 |
| 87 | MP0000858_altered_metastatic_potential | 1.12114277 |
| 88 | MP0004947_skin_inflammation | 1.07565951 |
| 89 | MP0005360_urolithiasis | 1.06439190 |
| 90 | MP0005503_abnormal_tendon_morphology | 1.06250138 |
| 91 | MP0000703_abnormal_thymus_morphology | 1.04498119 |
| 92 | MP0002998_abnormal_bone_remodeling | 1.03404975 |
| 93 | MP0005409_darkened_coat_color | 1.02783591 |
| 94 | MP0005670_abnormal_white_adipose | 1.01930034 |
| 95 | MP0003172_abnormal_lysosome_physiology | 1.01479192 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 1.00961622 |
| 97 | MP0005164_abnormal_response_to | 1.00823160 |
| 98 | MP0008058_abnormal_DNA_repair | 1.00402069 |
| 99 | MP0004885_abnormal_endolymph | 0.99620435 |
| 100 | MP0005365_abnormal_bile_salt | 0.99611976 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.99502453 |
| 102 | MP0000767_abnormal_smooth_muscle | 0.98539992 |
| 103 | MP0002933_joint_inflammation | 0.98482479 |
| 104 | MP0001851_eye_inflammation | 0.97903113 |
| 105 | MP0003136_yellow_coat_color | 0.97547335 |
| 106 | MP0002736_abnormal_nociception_after | 0.97189660 |
| 107 | MP0005085_abnormal_gallbladder_physiolo | 0.96203960 |
| 108 | MP0010094_abnormal_chromosome_stability | 0.96069630 |
| 109 | MP0003329_amyloid_beta_deposits | 0.94958337 |
| 110 | MP0004883_abnormal_blood_vessel | 0.94768238 |
| 111 | MP0002163_abnormal_gland_morphology | 0.94065442 |
| 112 | MP0009250_abnormal_appendicular_skeleto | 0.93843496 |
| 113 | MP0005253_abnormal_eye_physiology | 0.93263588 |
| 114 | MP0008004_abnormal_stomach_pH | 0.92657706 |
| 115 | MP0000372_irregular_coat_pigmentation | 0.91954056 |
| 116 | MP0003693_abnormal_embryo_hatching | 0.91884635 |
| 117 | MP0003077_abnormal_cell_cycle | 0.91827434 |
| 118 | MP0000230_abnormal_systemic_arterial | 0.91575029 |
| 119 | MP0004130_abnormal_muscle_cell | 0.91506527 |
| 120 | MP0005084_abnormal_gallbladder_morpholo | 0.88918610 |
| 121 | MP0005390_skeleton_phenotype | 0.87903035 |
| 122 | MP0005551_abnormal_eye_electrophysiolog | 0.87570560 |
| 123 | MP0002127_abnormal_cardiovascular_syste | 0.87543002 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.86940845 |
| 125 | MP0004215_abnormal_myocardial_fiber | 0.86209685 |
| 126 | MP0010030_abnormal_orbit_morphology | 0.85673292 |
| 127 | MP0008875_abnormal_xenobiotic_pharmacok | 0.83242904 |
| 128 | MP0000249_abnormal_blood_vessel | 0.82790642 |
| 129 | MP0003656_abnormal_erythrocyte_physiolo | 0.82514749 |
| 130 | MP0002009_preneoplasia | 0.82374034 |
| 131 | MP0001963_abnormal_hearing_physiology | 0.82293549 |
| 132 | MP0002139_abnormal_hepatobiliary_system | 0.81460605 |
| 133 | MP0002019_abnormal_tumor_incidence | 0.80554603 |
| 134 | MP0001614_abnormal_blood_vessel | 0.79423879 |
| 135 | MP0010329_abnormal_lipoprotein_level | 0.79366372 |
| 136 | MP0000026_abnormal_inner_ear | 0.78963885 |
| 137 | MP0003186_abnormal_redox_activity | 0.78682945 |
| 138 | MP0000534_abnormal_ureter_morphology | 0.78406894 |
| 139 | MP0000613_abnormal_salivary_gland | 0.77380452 |
| 140 | MP0004782_abnormal_surfactant_physiolog | 0.77277941 |
| 141 | MP0003866_abnormal_defecation | 0.76023959 |
| 142 | MP0006072_abnormal_retinal_apoptosis | 0.75588131 |
| 143 | MP0001544_abnormal_cardiovascular_syste | 0.75579497 |
| 144 | MP0005385_cardiovascular_system_phenoty | 0.75579497 |
| 145 | MP0003300_gastrointestinal_ulcer | 0.74154524 |
| 146 | * MP0003638_abnormal_response/metabolism_ | 0.73900753 |
| 147 | MP0002135_abnormal_kidney_morphology | 0.73532729 |
| 148 | MP0003567_abnormal_fetal_cardiomyocyte | 0.73212506 |
| 149 | MP0003943_abnormal_hepatobiliary_system | 0.73051160 |
| 150 | MP0003111_abnormal_nucleus_morphology | 0.72798793 |
| 151 | MP0003631_nervous_system_phenotype | 0.71280275 |
| 152 | MP0002133_abnormal_respiratory_system | 0.70680022 |
| 153 | MP0005388_respiratory_system_phenotype | 0.70680022 |
| 154 | MP0003279_aneurysm | 0.69205936 |
| 155 | MP0001188_hyperpigmentation | 0.68779529 |
| 156 | MP0002254_reproductive_system_inflammat | 0.68343338 |
| 157 | MP0002876_abnormal_thyroid_physiology | 0.67497411 |
| 158 | MP0003122_maternal_imprinting | 0.66607613 |
| 159 | MP0000537_abnormal_urethra_morphology | 0.66179866 |
| 160 | MP0001915_intracranial_hemorrhage | 0.63622119 |
| 161 | MP0003632_abnormal_nervous_system | 0.63430168 |
| 162 | MP0000163_abnormal_cartilage_morphology | 0.63304219 |
| 163 | MP0004133_heterotaxia | 0.63271498 |
| 164 | MP0004145_abnormal_muscle_electrophysio | 0.63063388 |
| 165 | MP0000313_abnormal_cell_death | 0.62752362 |
| 166 | MP0004381_abnormal_hair_follicle | 0.62232689 |
| 167 | MP0001849_ear_inflammation | 0.61876550 |
| 168 | MP0000371_diluted_coat_color | 0.61862395 |
| 169 | MP0003690_abnormal_glial_cell | 0.61462995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.43053428 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.77042304 |
| 3 | Stenosis of the external auditory canal (HP:0000402) | 4.35455294 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.17249171 |
| 5 | Myositis (HP:0100614) | 4.15827216 |
| 6 | Hemiplegia (HP:0002301) | 4.06701467 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.02167188 |
| 8 | Porencephaly (HP:0002132) | 3.92625254 |
| 9 | Diplopia (HP:0000651) | 3.90761339 |
| 10 | Abnormality of binocular vision (HP:0011514) | 3.90761339 |
| 11 | Methylmalonic aciduria (HP:0012120) | 3.77141810 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.63615287 |
| 13 | Petechiae (HP:0000967) | 3.55748537 |
| 14 | Reticulocytopenia (HP:0001896) | 3.54336483 |
| 15 | Orchitis (HP:0100796) | 3.47686200 |
| 16 | Optic neuritis (HP:0100653) | 3.43922379 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.43922379 |
| 18 | Abolished electroretinogram (ERG) (HP:0000550) | 3.40827503 |
| 19 | IgM deficiency (HP:0002850) | 3.40759580 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.38040551 |
| 21 | Abnormal number of erythroid precursors (HP:0012131) | 3.35430221 |
| 22 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.35236900 |
| 23 | Recurrent skin infections (HP:0001581) | 3.32834880 |
| 24 | Chronic otitis media (HP:0000389) | 3.28896983 |
| 25 | Cellulitis (HP:0100658) | 3.26648777 |
| 26 | Thrombocytosis (HP:0001894) | 3.23380401 |
| 27 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.16472215 |
| 28 | Increased corneal curvature (HP:0100692) | 3.13534938 |
| 29 | Keratoconus (HP:0000563) | 3.13534938 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 3.11492702 |
| 31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.10325528 |
| 32 | Recurrent viral infections (HP:0004429) | 3.06353639 |
| 33 | Recurrent fungal infections (HP:0002841) | 3.06128806 |
| 34 | Methylmalonic acidemia (HP:0002912) | 3.04166019 |
| 35 | Short tibia (HP:0005736) | 3.00764251 |
| 36 | Prolonged bleeding time (HP:0003010) | 2.99245218 |
| 37 | Hemiparesis (HP:0001269) | 2.98603160 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95375974 |
| 39 | Obstructive lung disease (HP:0006536) | 2.95375974 |
| 40 | Spontaneous hematomas (HP:0007420) | 2.93784109 |
| 41 | Confusion (HP:0001289) | 2.91072547 |
| 42 | Meningitis (HP:0001287) | 2.90279997 |
| 43 | Agammaglobulinemia (HP:0004432) | 2.84507977 |
| 44 | Increased cerebral lipofuscin (HP:0011813) | 2.82846354 |
| 45 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.82718823 |
| 46 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.82163041 |
| 47 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76856268 |
| 48 | True hermaphroditism (HP:0010459) | 2.76512250 |
| 49 | Abnormality of the nasal septum (HP:0000419) | 2.75797687 |
| 50 | Recurrent pneumonia (HP:0006532) | 2.75308379 |
| 51 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.73670747 |
| 52 | Recurrent cutaneous fungal infections (HP:0011370) | 2.73670747 |
| 53 | Vasculitis (HP:0002633) | 2.71823055 |
| 54 | Adactyly (HP:0009776) | 2.68935247 |
| 55 | Prostate neoplasm (HP:0100787) | 2.67100933 |
| 56 | Congenital, generalized hypertrichosis (HP:0004540) | 2.64935857 |
| 57 | Agitation (HP:0000713) | 2.64669435 |
| 58 | Inflammation of the large intestine (HP:0002037) | 2.63539267 |
| 59 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.55793745 |
| 60 | Chromsome breakage (HP:0040012) | 2.54823744 |
| 61 | Colitis (HP:0002583) | 2.52872909 |
| 62 | Short femoral neck (HP:0100864) | 2.52314406 |
| 63 | Recurrent lower respiratory tract infections (HP:0002783) | 2.51320953 |
| 64 | Gingivitis (HP:0000230) | 2.48924886 |
| 65 | Cervical subluxation (HP:0003308) | 2.48893622 |
| 66 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.47702794 |
| 67 | Short hallux (HP:0010109) | 2.47545234 |
| 68 | Basal ganglia calcification (HP:0002135) | 2.47212989 |
| 69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.46628138 |
| 70 | Dysostosis multiplex (HP:0000943) | 2.45596108 |
| 71 | Beaking of vertebral bodies (HP:0004568) | 2.45578182 |
| 72 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.43886855 |
| 73 | Pallor (HP:0000980) | 2.43653603 |
| 74 | Gastrointestinal inflammation (HP:0004386) | 2.43391279 |
| 75 | Osteomyelitis (HP:0002754) | 2.39485512 |
| 76 | Duplicated collecting system (HP:0000081) | 2.36398355 |
| 77 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.36201384 |
| 78 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.34963503 |
| 79 | Epistaxis (HP:0000421) | 2.32494786 |
| 80 | Ovoid vertebral bodies (HP:0003300) | 2.32483537 |
| 81 | Fused cervical vertebrae (HP:0002949) | 2.31858947 |
| 82 | Mucopolysacchariduria (HP:0008155) | 2.31775455 |
| 83 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.31775455 |
| 84 | Purpura (HP:0000979) | 2.31030957 |
| 85 | Reduced antithrombin III activity (HP:0001976) | 2.27952415 |
| 86 | Pancreatic fibrosis (HP:0100732) | 2.27266119 |
| 87 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.26903795 |
| 88 | Hyperglycinemia (HP:0002154) | 2.25535906 |
| 89 | Irregular vertebral endplates (HP:0003301) | 2.24966116 |
| 90 | Keratoconjunctivitis sicca (HP:0001097) | 2.23944166 |
| 91 | Recurrent bronchitis (HP:0002837) | 2.23176736 |
| 92 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.21035505 |
| 93 | Pancreatic cysts (HP:0001737) | 2.20972243 |
| 94 | Abnormality of the renal collecting system (HP:0004742) | 2.20154176 |
| 95 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.19684853 |
| 96 | Short 4th metacarpal (HP:0010044) | 2.19684853 |
| 97 | Encephalitis (HP:0002383) | 2.18144819 |
| 98 | Abnormality of T cell physiology (HP:0011840) | 2.17558586 |
| 99 | Abnormality of the prostate (HP:0008775) | 2.16781055 |
| 100 | Hematochezia (HP:0002573) | 2.16767033 |
| 101 | Conjunctival telangiectasia (HP:0000524) | 2.15897644 |
| 102 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.15827114 |
| 103 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.15827114 |
| 104 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.15827114 |
| 105 | Pulmonary infiltrates (HP:0002113) | 2.15036996 |
| 106 | Agnosia (HP:0010524) | 2.13572285 |
| 107 | 3-Methylglutaconic aciduria (HP:0003535) | 2.13167481 |
| 108 | Myocardial infarction (HP:0001658) | 2.13042843 |
| 109 | Decreased central vision (HP:0007663) | 2.12971483 |
| 110 | Clubbing of toes (HP:0100760) | 2.12612793 |
| 111 | Periodontitis (HP:0000704) | 2.12396721 |
| 112 | Systemic lupus erythematosus (HP:0002725) | 2.11967566 |
| 113 | Bone cyst (HP:0012062) | 2.11068537 |
| 114 | Hemoptysis (HP:0002105) | 2.10831130 |
| 115 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.10809170 |
| 116 | Interstitial pulmonary disease (HP:0006530) | 2.10689467 |
| 117 | Keratoconjunctivitis (HP:0001096) | 2.10607128 |
| 118 | Abnormality of the nasal mucosa (HP:0000433) | 2.10475648 |
| 119 | Autoimmune thrombocytopenia (HP:0001973) | 2.06657762 |
| 120 | Arterial thrombosis (HP:0004420) | 2.06164091 |
| 121 | Patchy hypopigmentation of hair (HP:0011365) | 2.05631389 |
| 122 | Pustule (HP:0200039) | 2.04709007 |
| 123 | Leukopenia (HP:0001882) | 2.04516092 |
| 124 | Type I transferrin isoform profile (HP:0003642) | 2.03636032 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 2.03051885 |
| 126 | Hypoplasia of the ulna (HP:0003022) | 2.01494730 |
| 127 | Increased IgE level (HP:0003212) | 2.01300396 |
| 128 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.00787860 |
| 129 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00787860 |
| 130 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00787860 |
| 131 | Humeroradial synostosis (HP:0003041) | 2.00118060 |
| 132 | Synostosis involving the elbow (HP:0003938) | 2.00118060 |
| 133 | Fibular hypoplasia (HP:0003038) | 1.97522225 |
| 134 | Leukocytosis (HP:0001974) | 1.97296718 |
| 135 | Panhypogammaglobulinemia (HP:0003139) | 1.97077244 |
| 136 | Gingival bleeding (HP:0000225) | 1.95562281 |
| 137 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.94710330 |
| 138 | Hypergammaglobulinemia (HP:0010702) | 1.94688955 |
| 139 | Stomatitis (HP:0010280) | 1.93996939 |
| 140 | White forelock (HP:0002211) | 1.92897786 |
| 141 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.92892994 |
| 142 | Asplenia (HP:0001746) | 1.92619507 |
| 143 | Albinism (HP:0001022) | 1.92321830 |
| 144 | Acute myeloid leukemia (HP:0004808) | 1.92162985 |
| 145 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.91953307 |
| 146 | Synostosis of carpal bones (HP:0005048) | 1.91692169 |
| 147 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.91471632 |
| 148 | Joint stiffness (HP:0001387) | 1.91023014 |
| 149 | Congenital sensorineural hearing impairment (HP:0008527) | 1.90903076 |
| 150 | Meningioma (HP:0002858) | 1.90900520 |
| 151 | Abnormal platelet function (HP:0011869) | 1.90741403 |
| 152 | Impaired platelet aggregation (HP:0003540) | 1.90741403 |
| 153 | Birth length less than 3rd percentile (HP:0003561) | 1.90392137 |
| 154 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.89708819 |
| 155 | Mucosal telangiectasiae (HP:0100579) | 1.89026522 |
| 156 | Poor head control (HP:0002421) | 1.88513066 |
| 157 | Gastrointestinal stroma tumor (HP:0100723) | 1.88385616 |
| 158 | Action tremor (HP:0002345) | 1.87940150 |
| 159 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.87873903 |
| 160 | Lymphopenia (HP:0001888) | 1.87569991 |
| 161 | Short humerus (HP:0005792) | 1.87136168 |
| 162 | Glomerulonephritis (HP:0000099) | 1.86335414 |
| 163 | Skin ulcer (HP:0200042) | 1.85909180 |
| 164 | Short 1st metacarpal (HP:0010034) | 1.85767293 |
| 165 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.85767293 |
| 166 | Aplastic anemia (HP:0001915) | 1.84832794 |
| 167 | Hypoplasia of the odontoid process (HP:0003311) | 1.84687524 |
| 168 | Myelodysplasia (HP:0002863) | 1.84414179 |
| 169 | Pendular nystagmus (HP:0012043) | 1.84050464 |
| 170 | Anhidrosis (HP:0000970) | 1.83931476 |
| 171 | Neutropenia (HP:0001875) | 1.83517678 |
| 172 | Bile duct proliferation (HP:0001408) | 1.83348612 |
| 173 | Abnormal biliary tract physiology (HP:0012439) | 1.83348612 |
| 174 | Chronic sinusitis (HP:0011109) | 1.82846152 |
| 175 | Amaurosis fugax (HP:0100576) | 1.82561086 |
| 176 | Flared iliac wings (HP:0002869) | 1.81911952 |
| 177 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.80333137 |
| 178 | Abnormality of the vertebral endplates (HP:0005106) | 1.79942267 |
| 179 | Lymphangioma (HP:0100764) | 1.79576552 |
| 180 | Hypoplasia of the uterus (HP:0000013) | 1.78246822 |
| 181 | Mesangial abnormality (HP:0001966) | 1.77113179 |
| 182 | Cerebral hemorrhage (HP:0001342) | 1.76834704 |
| 183 | Disproportionate short-trunk short stature (HP:0003521) | 1.76438699 |
| 184 | Complement deficiency (HP:0004431) | 1.74318818 |
| 185 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.72583155 |
| 186 | Progressive neurologic deterioration (HP:0002344) | 1.71780947 |
| 187 | Premature rupture of membranes (HP:0001788) | 1.70662029 |
| 188 | Polycythemia (HP:0001901) | 1.70565608 |
| 189 | Hypoalphalipoproteinemia (HP:0003233) | 1.70345107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.24320876 |
| 2 | MAP3K14 | 3.19033331 |
| 3 | MAP3K12 | 3.06190651 |
| 4 | IRAK4 | 2.93166751 |
| 5 | MAP4K1 | 2.90642653 |
| 6 | PDK2 | 2.87645738 |
| 7 | NME2 | 2.78043946 |
| 8 | IRAK3 | 2.71543854 |
| 9 | EPHB2 | 2.64946654 |
| 10 | TIE1 | 2.57420365 |
| 11 | KIT | 2.57154991 |
| 12 | TGFBR2 | 2.41731109 |
| 13 | IKBKB | 2.33505557 |
| 14 | KDR | 2.28647713 |
| 15 | TBK1 | 2.09089566 |
| 16 | BCKDK | 2.06545656 |
| 17 | JAK3 | 2.03329043 |
| 18 | TYK2 | 2.02290901 |
| 19 | TEC | 2.02089334 |
| 20 | PIM2 | 1.98820933 |
| 21 | BTK | 1.84055670 |
| 22 | IKBKE | 1.80646135 |
| 23 | FRK | 1.78999000 |
| 24 | STK16 | 1.76495947 |
| 25 | VRK1 | 1.73505884 |
| 26 | CSF1R | 1.71429173 |
| 27 | FER | 1.67496937 |
| 28 | CLK1 | 1.67090678 |
| 29 | MYLK | 1.62832377 |
| 30 | TXK | 1.53564020 |
| 31 | TGFBR1 | 1.42019654 |
| 32 | PIM1 | 1.41323387 |
| 33 | MAP2K3 | 1.35936187 |
| 34 | PTK2B | 1.35819107 |
| 35 | EIF2AK2 | 1.35787435 |
| 36 | MATK | 1.31823595 |
| 37 | LYN | 1.27093403 |
| 38 | PINK1 | 1.26545597 |
| 39 | SYK | 1.24599903 |
| 40 | ZAP70 | 1.22138265 |
| 41 | ZAK | 1.17902480 |
| 42 | STK10 | 1.17488817 |
| 43 | FLT3 | 1.15616264 |
| 44 | LIMK1 | 1.15385703 |
| 45 | CHUK | 1.14713281 |
| 46 | PRKD2 | 1.11884626 |
| 47 | RIPK4 | 1.08761530 |
| 48 | YES1 | 1.08235195 |
| 49 | MOS | 1.06278552 |
| 50 | NUAK1 | 1.04891373 |
| 51 | CSNK1G1 | 1.03004032 |
| 52 | ERBB4 | 1.01816376 |
| 53 | LCK | 1.00768403 |
| 54 | MST4 | 1.00090586 |
| 55 | NLK | 0.99846057 |
| 56 | PBK | 0.98559937 |
| 57 | TRPM7 | 0.97402516 |
| 58 | JAK1 | 0.96002710 |
| 59 | MAP4K2 | 0.94621198 |
| 60 | MKNK1 | 0.94163543 |
| 61 | STK4 | 0.94034320 |
| 62 | HCK | 0.93786501 |
| 63 | BMPR1B | 0.93094152 |
| 64 | BMPR2 | 0.92493791 |
| 65 | CSNK1G3 | 0.91919456 |
| 66 | TLK1 | 0.91916702 |
| 67 | EPHB1 | 0.91329450 |
| 68 | ADRBK2 | 0.91072370 |
| 69 | VRK2 | 0.89686947 |
| 70 | NEK9 | 0.89618083 |
| 71 | CSK | 0.88727615 |
| 72 | RPS6KA4 | 0.88332101 |
| 73 | GRK1 | 0.86807448 |
| 74 | CSNK1A1L | 0.86490796 |
| 75 | IRAK1 | 0.85783234 |
| 76 | PAK4 | 0.82387549 |
| 77 | DYRK3 | 0.79627941 |
| 78 | EIF2AK1 | 0.76790352 |
| 79 | FGR | 0.76773789 |
| 80 | TAOK3 | 0.76567968 |
| 81 | SIK3 | 0.76433167 |
| 82 | ROCK2 | 0.76232725 |
| 83 | GRK7 | 0.75039764 |
| 84 | EIF2AK3 | 0.72741096 |
| 85 | ADRBK1 | 0.71655162 |
| 86 | TNIK | 0.71308256 |
| 87 | LRRK2 | 0.71161707 |
| 88 | CSNK1G2 | 0.70885647 |
| 89 | PLK2 | 0.70513154 |
| 90 | FGFR2 | 0.69342433 |
| 91 | FES | 0.68840227 |
| 92 | IGF1R | 0.68207650 |
| 93 | CDK7 | 0.67098353 |
| 94 | MKNK2 | 0.66476339 |
| 95 | MAPK7 | 0.64488338 |
| 96 | PRKCE | 0.64204939 |
| 97 | TESK1 | 0.63697193 |
| 98 | ITK | 0.61855337 |
| 99 | IRAK2 | 0.61562791 |
| 100 | WEE1 | 0.59240590 |
| 101 | GRK5 | 0.58666337 |
| 102 | PLK4 | 0.58338831 |
| 103 | EPHA3 | 0.57728747 |
| 104 | DDR2 | 0.57033376 |
| 105 | FGFR3 | 0.54933824 |
| 106 | ACVR1B | 0.54613715 |
| 107 | RPS6KA5 | 0.54406181 |
| 108 | INSRR | 0.53926384 |
| 109 | PRKCD | 0.50407622 |
| 110 | GRK6 | 0.49714747 |
| 111 | ATR | 0.49683731 |
| 112 | ROCK1 | 0.49600380 |
| 113 | ERN1 | 0.49400225 |
| 114 | JAK2 | 0.48576929 |
| 115 | CDK19 | 0.47504475 |
| 116 | ERBB2 | 0.47141690 |
| 117 | MAPKAPK2 | 0.46988244 |
| 118 | ABL1 | 0.46631404 |
| 119 | CDK9 | 0.41061129 |
| 120 | MAPKAPK5 | 0.40899612 |
| 121 | STK38L | 0.40216155 |
| 122 | CDK8 | 0.39964055 |
| 123 | RPS6KA6 | 0.39711692 |
| 124 | EGFR | 0.39387760 |
| 125 | CSNK1A1 | 0.39335391 |
| 126 | WNK3 | 0.38492856 |
| 127 | ABL2 | 0.37601164 |
| 128 | CDK4 | 0.37550575 |
| 129 | INSR | 0.37041053 |
| 130 | PIK3CG | 0.36955555 |
| 131 | PRKG2 | 0.36661851 |
| 132 | TNK2 | 0.36417244 |
| 133 | MAPK12 | 0.35786914 |
| 134 | MAP3K3 | 0.35281642 |
| 135 | BRSK2 | 0.34248402 |
| 136 | PRKCG | 0.33868812 |
| 137 | GSK3A | 0.33566488 |
| 138 | SRC | 0.33415543 |
| 139 | FYN | 0.29706951 |
| 140 | PRKD1 | 0.28908650 |
| 141 | FGFR1 | 0.28794314 |
| 142 | MUSK | 0.28148119 |
| 143 | RPS6KB2 | 0.27908828 |
| 144 | RPS6KC1 | 0.27795335 |
| 145 | RPS6KL1 | 0.27795335 |
| 146 | PRKCQ | 0.27490932 |
| 147 | OXSR1 | 0.26469905 |
| 148 | PRKCA | 0.24699422 |
| 149 | RIPK1 | 0.22826685 |
| 150 | PAK6 | 0.21711627 |
| 151 | MET | 0.21599165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.97025431 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 2.71897684 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.55210313 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.51747563 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.48927908 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.47679240 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.39225682 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.36257406 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.09746252 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.96351452 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.95243453 |
| 12 | Malaria_Homo sapiens_hsa05144 | 1.92371166 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.90305861 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.89705437 |
| 15 | Mismatch repair_Homo sapiens_hsa03430 | 1.84859220 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.83506055 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83281417 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79764647 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75561082 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.75346986 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.74790452 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.73242954 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.70876654 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68425720 |
| 25 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.68282941 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.66523643 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.65393341 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64769376 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.64508453 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.63481539 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.62266565 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.60736979 |
| 33 | Base excision repair_Homo sapiens_hsa03410 | 1.56998170 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.54210451 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.53268119 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.52517895 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.47380324 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.41754658 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40107853 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.40037664 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39358017 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39187475 |
| 43 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.38640839 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.37850623 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.37037983 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36579537 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34819799 |
| 48 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.34792920 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.34400411 |
| 50 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.31867063 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 1.29733663 |
| 52 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29016074 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 1.28112598 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 1.27659517 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27283227 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.23902613 |
| 57 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.20123965 |
| 58 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.18467303 |
| 59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.16987666 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 1.16841271 |
| 61 | RNA polymerase_Homo sapiens_hsa03020 | 1.16840296 |
| 62 | Asthma_Homo sapiens_hsa05310 | 1.15874733 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14899990 |
| 64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.12668354 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.12041562 |
| 66 | Proteasome_Homo sapiens_hsa03050 | 1.10461698 |
| 67 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08400387 |
| 68 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.06955843 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.06096628 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.05775302 |
| 71 | Retinol metabolism_Homo sapiens_hsa00830 | 1.03159431 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02667156 |
| 73 | Spliceosome_Homo sapiens_hsa03040 | 1.01896200 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 1.01862654 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.01767853 |
| 76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.01705835 |
| 77 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.01466117 |
| 78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.01366821 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01362829 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01229396 |
| 81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99339309 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98541070 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97312571 |
| 84 | Hepatitis B_Homo sapiens_hsa05161 | 0.96047255 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94379912 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93451359 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.92339843 |
| 88 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.92086338 |
| 89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92038782 |
| 90 | Protein export_Homo sapiens_hsa03060 | 0.90374687 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.88688204 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88572830 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88020311 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87219956 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.86846257 |
| 96 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.86156358 |
| 97 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.84834811 |
| 98 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.84425955 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.83475760 |
| 100 | Phototransduction_Homo sapiens_hsa04744 | 0.83097433 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81847190 |
| 102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81641929 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81349318 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80086732 |
| 105 | Histidine metabolism_Homo sapiens_hsa00340 | 0.79734502 |
| 106 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.77550986 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76899610 |
| 108 | Alzheimers disease_Homo sapiens_hsa05010 | 0.75094384 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.75009241 |
| 110 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73571232 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73431516 |
| 112 | RNA degradation_Homo sapiens_hsa03018 | 0.73050931 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72905113 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72271979 |
| 115 | Cell cycle_Homo sapiens_hsa04110 | 0.71801507 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70275826 |
| 117 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69873134 |
| 118 | Hepatitis C_Homo sapiens_hsa05160 | 0.69232561 |
| 119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69226808 |
| 120 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68239272 |
| 121 | Parkinsons disease_Homo sapiens_hsa05012 | 0.65585249 |
| 122 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60772269 |
| 123 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.60762841 |
| 124 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60652711 |
| 125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60280768 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58573152 |
| 127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57482393 |
| 128 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56760823 |
| 129 | HTLV-I infection_Homo sapiens_hsa05166 | 0.54886986 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53865686 |
| 131 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53759995 |
| 132 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52708189 |
| 133 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52526456 |
| 134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50741670 |
| 135 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49681745 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48728458 |
| 137 | ABC transporters_Homo sapiens_hsa02010 | 0.48522915 |
| 138 | Purine metabolism_Homo sapiens_hsa00230 | 0.48341880 |
| 139 | Morphine addiction_Homo sapiens_hsa05032 | 0.46171554 |
| 140 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44823337 |
| 141 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43034683 |
| 142 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42573231 |
| 143 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42267548 |
| 144 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41741401 |
| 145 | Mineral absorption_Homo sapiens_hsa04978 | 0.41578630 |
| 146 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40591497 |
| 147 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40034562 |
| 148 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.39629857 |
| 149 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39317009 |
| 150 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38175407 |
| 151 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38102973 |
| 152 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38038752 |
| 153 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37605633 |
| 154 | * Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37155964 |
| 155 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.36502688 |
| 156 | Bile secretion_Homo sapiens_hsa04976 | 0.35652723 |
| 157 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32932311 |
| 158 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 0.32219936 |
| 159 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30466524 |
| 160 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28335723 |
| 161 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.27705904 |
| 162 | Axon guidance_Homo sapiens_hsa04360 | 0.27669732 |

